Venrock Healthcare Capital Partners EG, L.P. is 10% Owner at KalVista Pharmaceuticals, Inc. (KALV). They have made 3 open-market trades across 2 companies since 2022, most recently 2026-03-26.
CIK 0001808512
2 open-market purchases totalling $9.6M since 2022, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| KALV | 5,129,500 | $138.4M |
| TCDA | 9,050,064 | $977K |
| Total | $139.4M |
Shares reported on the most recent Form 4, priced at the 2026-03-27 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.